Dr. John Cush RheumNow
7 years 11 months ago
The "Type" of person you are often is displayed with how you manage authority
Dr. John Cush RheumNow
7 years 11 months ago
CORRECTION: mm! Guidelines on CT pulm nodules-no F/U needed for solid nodules <6mm in low risk pts (age,smoking, morphology); but larger (6-8mm), suspicious nodules should have 6 & 12 mos F/U images. Some 8cm or more nodules require more freq assessments https://t.co/Nl6zV3VQg1
Dr. John Cush RheumNow
7 years 11 months ago
“This is not your responsibility but it is your problem.” — Cheryl Strayed
I believe the converse is more important to what we need to teach our patients - "This is not just your problem, this is now your responsibility"
Dr. John Cush RheumNow
7 years 11 months ago
Safety and Immunogenicity is one of nine educational videos available in the "Therapeutic Update: Biosimilars in Rheumatology" video series, sponsored by Sandoz, Inc. and now available on RheumNow. https://t.co/1vmnEJqOSi
Dr. John Cush RheumNow
7 years 11 months ago
FDA Approves Gamifant (emapalumab-lzsg) for Primary Hemophagocytic Lymphohistiocytosis https://t.co/YALlc0XdKh
Angus Worthing MD AngusWorthing
7 years 11 months ago
Are you a US rheumatologist interested in what the midterm election results mean for us? 100 members of the next Congress are NEW and we need to meet them! Please invest in #RheumPAC NOW. Help advance arthritis research, reform step therapy & other causes!
https://t.co/pcRkh6eLfJ
Dr. John Cush RheumNow
7 years 11 months ago
Sudden discontinuation of duloxetine may have Adverse Events in up to 44% - dizziness, nauseam headache, paresthesia, vomiting, irritability, nightmares. Instead, its rec to gradually reduce dose over 2 weeks before D/C of duloxetine.https://t.co/aSGU0CVldB
Dr. John Cush RheumNow
7 years 11 months ago
New Guidelines on CT pulm nodules-no F/U needed for solid nodules <6cm in low risk pts (age, smoking, morphology); but larger (6-8cm), suspicious nodules should have 6 and 12 mos F/U images. Some 8cm or more nodules require more freq assessments https://t.co/Nl6zV3VQg1
Dr. John Cush RheumNow
7 years 11 months ago
The Next Best Meeting in Rheumatology is coming - RHEUMNOW LIVE - March 22-24 2019 in beautiful downtown Fort Worth. Short Lectures, interactive sessions, Q&A panels, TED (like) Talks, digital, streaming and much more. You dont want to miss this meeting! https://t.co/5TVg0Frsbf
Dr. John Cush RheumNow
7 years 11 months ago
79 pts Ultrasound evidence of gout (tophus or double contour sign) @ knee or MTP1 were given ULT for 6 mos. Those achieving very low uric acid levels showed US decrease in tophus (r = 0.54) and double contour sign disappearance (r=−0.59) https://t.co/4W0EX8swDo
You may not want my advice, but I’m going to give it to you anyway.
Such are the words spoken by someone you’re usually not inclined to listen to, such as a parent, boss or “know it all” partner. I happen to be none of these, so it may behoove you to consider these tenets as they may enhance your career in rheumatology.
Lancet has published a comparative effectiveness study examining the the value of night splints (conservative treatment) vs local injection for patients with carpal tunnel syndrome.
Lancet reports on the safety of over 1 million arthroscopic partial meniscectomies done in the United Kingdom and found a low overall risk in the first 90 days.
They examined Hospital Episode Statistics on 1,088,782 arthroscopic partial meniscectomies (1997-2017); 699 965 of which were eligible for analysis. They sought to identify complications occurring in the 90 days after the index procedure.
Dr. John Cush RheumNow
7 years 11 months ago
Large claims analysis shows that lipid screening was suboptimal (37%) among RA patients but was higher when RA patients visited a rheumatologist and a non-rheumatology clinicians (~55%). https://t.co/S4Op22LOoY
Immunometabolism Network ImmunoMet
7 years 11 months ago
A step-by-step guide to academic publication for young investigators #SciComm #PhD #postdoc #scientist https://t.co/yEnd2xJelZ https://t.co/kyZiQSX7L9

